2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Ataxia: new trials by email Literature Review of Ataxia trials Research Report on Ataxia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 BIIB132, BIIB132-Matching Placebo - Spinocerebellar Ataxia Type 3 | Phase 1 | Terminated | Biogen | 8 | 2022-02-02 | 2023-08-04 |
| A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants TAK-831 Oral Suspension, TAK-831 Placebo, TAK-831 Tablet - Schizophrenia, Cerebellar Ataxia | Phase 1 | Terminated | Neurocrine Biosciences | 110 | 2015-09-23 | 2021-06-14 |
Cerebellar Ataxia (1) · Machado-Joseph Disease (1) · Schizophrenia (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebellar Diseases (2) · Dyskinesias (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Cerebellar Ataxia (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Mental Disorders (1) · Neurodegenerative Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Biogen (1) · Neurocrine Biosciences (1)
United Kingdom (2) · Germany (1) · Israel (1) · Netherlands (1) · Portugal (1) · United States (1)
2015 (1)